These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 38786018)

  • 1. The Importance of HHLA2 in Solid Tumors-A Review of the Literature.
    Kula A; Koszewska D; Kot A; Dawidowicz M; Mielcarska S; Waniczek D; Świętochowska E
    Cells; 2024 May; 13(10):. PubMed ID: 38786018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. KIR3DL3-HHLA2 and TMIGD2-HHLA2 pathways: The dual role of HHLA2 in immune responses and its potential therapeutic approach for cancer immunotherapy.
    Li Y; Lv C; Yu Y; Wu B; Zhang Y; Lang Q; Liang Z; Zhong C; Shi Y; Han S; Xu F; Tian Y
    J Adv Res; 2023 May; 47():137-150. PubMed ID: 35933091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HHLA2 immune-regulatory roles in cancer.
    Mortezaee K
    Biomed Pharmacother; 2023 Jun; 162():114639. PubMed ID: 37011487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HHLA2: An Emerging Immune Checkpoint for Cancer Immunotherapy.
    Cao Z; Wang Y; Cheng SC; He N
    J Leukoc Biol; 2024 Jul; ():. PubMed ID: 38973642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. KIR3DL3-HHLA2 is a human immunosuppressive pathway and a therapeutic target.
    Wei Y; Ren X; Galbo PM; Moerdler S; Wang H; Sica RA; Etemad-Gilbertson B; Shi L; Zhu L; Tang X; Lin Q; Peng M; Guan F; Zheng D; Chinai JM; Zang X
    Sci Immunol; 2021 Jul; 6(61):. PubMed ID: 34244312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human endogenous retrovirus-H long terminal repeat-associating 2: The next immune checkpoint for antitumour therapy.
    Ying H; Xu J; Zhang X; Liang T; Bai X
    EBioMedicine; 2022 May; 79():103987. PubMed ID: 35439678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The third group of the B7-CD28 immune checkpoint family: HHLA2, TMIGD2, B7x, and B7-H3.
    Janakiram M; Shah UA; Liu W; Zhao A; Schoenberg MP; Zang X
    Immunol Rev; 2017 Mar; 276(1):26-39. PubMed ID: 28258693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. KIR3DL3 Is an Inhibitory Receptor for HHLA2 that Mediates an Alternative Immunoinhibitory Pathway to PD1.
    Bhatt RS; Berjis A; Konge JC; Mahoney KM; Klee AN; Freeman SS; Chen CH; Jegede OA; Catalano PJ; Pignon JC; Sticco-Ivins M; Zhu B; Hua P; Soden J; Zhu J; McDermott DF; Arulanandam AR; Signoretti S; Freeman GJ
    Cancer Immunol Res; 2021 Feb; 9(2):156-169. PubMed ID: 33229411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological suppression of HHLA2 glycosylation restores anti-tumor immunity in colorectal cancer.
    Zhang D; Xie J; Sun F; Xu R; Liu W; Xu J; Huang X; Zhang G
    Cancer Lett; 2024 May; 589():216819. PubMed ID: 38522775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wide Expression and Significance of Alternative Immune Checkpoint Molecules, B7x and HHLA2, in PD-L1-Negative Human Lung Cancers.
    Cheng H; Borczuk A; Janakiram M; Ren X; Lin J; Assal A; Halmos B; Perez-Soler R; Zang X
    Clin Cancer Res; 2018 Apr; 24(8):1954-1964. PubMed ID: 29374053
    [No Abstract]   [Full Text] [Related]  

  • 11. The Expression Patterns and Associated Clinical Parameters of Human Endogenous Retrovirus-H Long Terminal Repeat-Associating Protein 2 and Transmembrane and Immunoglobulin Domain Containing 2 in Oral Squamous Cell Carcinoma.
    Xiao Y; Li H; Yang LL; Mao L; Wu CC; Zhang WF; Sun ZJ
    Dis Markers; 2019; 2019():5421985. PubMed ID: 31089395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advancements in the B7/CD28 immune checkpoint families: new biology and clinical therapeutic strategies.
    Pulanco MC; Madsen AT; Tanwar A; Corrigan DT; Zang X
    Cell Mol Immunol; 2023 Jul; 20(7):694-713. PubMed ID: 37069229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HHLA2 Activates the JAK/STAT Signaling Pathway by Binding to TMIGD2 in Hepatocellular Carcinoma Cells.
    Guo H; Zhang C; Tang X; Zhang T; Liu Y; Yu H; Li Y; Wang R
    Inflammation; 2022 Aug; 45(4):1585-1599. PubMed ID: 35175496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel immune scoring dynamic nomograms based on B7-H3, B7-H4, and HHLA2: Potential prediction in survival and immunotherapeutic efficacy for gallbladder cancer.
    Lv C; Han S; Wu B; Liang Z; Li Y; Zhang Y; Lang Q; Zhong C; Fu L; Yu Y; Xu F; Tian Y
    Front Immunol; 2022; 13():984172. PubMed ID: 36159808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression, Clinical Significance, and Receptor Identification of the Newest B7 Family Member HHLA2 Protein.
    Janakiram M; Chinai JM; Fineberg S; Fiser A; Montagna C; Medavarapu R; Castano E; Jeon H; Ohaegbulam KC; Zhao R; Zhao A; Almo SC; Sparano JA; Zang X
    Clin Cancer Res; 2015 May; 21(10):2359-66. PubMed ID: 25549724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. B7-H7: A potential target for cancer immunotherapy.
    Su Q; Du J; Xiong X; Xie X; Wang L
    Int Immunopharmacol; 2023 Aug; 121():110403. PubMed ID: 37290327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different clinical significance of novel B7 family checkpoints VISTA and HHLA2 in human lung adenocarcinoma.
    Long L; Zhang L; Yang Y; Zhou Y; Chen H
    Immunotherapy; 2022 Apr; 14(6):419-431. PubMed ID: 35187955
    [No Abstract]   [Full Text] [Related]  

  • 18. HHLA2 is a member of the B7 family and inhibits human CD4 and CD8 T-cell function.
    Zhao R; Chinai JM; Buhl S; Scandiuzzi L; Ray A; Jeon H; Ohaegbulam KC; Ghosh K; Zhao A; Scharff MD; Zang X
    Proc Natl Acad Sci U S A; 2013 Jun; 110(24):9879-84. PubMed ID: 23716685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human Endogenous Retrovirus-H Long Terminal Repeat- Associating Protein 2 (HHLA2) is a Novel Immune Checkpoint Protein in Lung Cancer which Predicts Survival.
    Farrag MS; Ibrahim EM; El-Hadidy TA; Akl MF; Elsergany AR; Abdelwahab HW
    Asian Pac J Cancer Prev; 2021 Jun; 22(6):1883-1889. PubMed ID: 34181347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon Gamma-Induced Interferon Regulatory Factor 1 Activates Transcription of HHLA2 and Induces Immune Escape of Hepatocellular Carcinoma Cells.
    Wang R; Guo H; Tang X; Zhang T; Liu Y; Zhang C; Yu H; Li Y
    Inflammation; 2022 Feb; 45(1):308-330. PubMed ID: 34536158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.